Retracted: Evaluation of lncRNA FOXD3-AS1 as a Biomarker for Early-Stage Lung Cancer Diagnosis and Subtype Identification

Detalles Bibliográficos
Autor principal: and Alternative Medicine, Evidence-Based Complementary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567180/
https://www.ncbi.nlm.nih.gov/pubmed/37829632
http://dx.doi.org/10.1155/2023/9782478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567180/
https://www.ncbi.nlm.nih.gov/pubmed/37829632
http://dx.doi.org/10.1155/2023/9782478

Ejemplares similares